Anupam Rasayan India has extended a long-term deal for the delivery of patented life science specialty chemicals for the next three years on an exclusive basis with one of the top German multinationals, valued at USD 53 million or Rs 436 crore in revenue. This renewal is in compliance with the automatic renewal provision incorporated by reference into the long-term agreement between the parties, which was executed three years ago.
Anupam Rasayan Limited has previously agreed to supply a top American multinational firm with new age specialty chemical advanced intermediate for the next five years in a letter of intent for USD 46 million or Rs 380 crore. The future multipurpose manufacturing facilities will produce this item. Anupam Rasayan Limited’s growth prospects in the market for specialised chemicals are anticipated to be further boosted by this new breakthrough with the American multinational corporation.
The business has signed contracts to deliver its goods to three international corporations within the past month.
Yesterday the scrip closed at Rs 1130.25 and today it opened at Rs 1131.05 and is currently trading at Rs 1136 on the BSE. Till now it has touched a high and low of Rs 1153.50 and 1131.05 respectively. So far 8,787 shares were traded over the counter.
The BSE group ‘A’ stock of face value Rs 10 has touched a 52-week high of Rs 1224.20 and a 52-week low of Rs 547.10. Current market cap of the company is Rs 12,243.98 crore.
Anupam Rasayan India (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. 60.81% of the company’s shares are held by the promoters, while institutions and non-institutions hold 13.50% and 25.69%, respectively.